Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Wo2000062778a1 dasatinib google patents?

See the DrugPatentWatch profile for dasatinib

What is WO2000062778A1 (and how does it relate to dasatinib)?

WO2000062778A1 is a published patent application (WO format) identified by the number WO2000062778. To confirm whether it specifically covers dasatinib, I would need the exact title/abstract (or at least the assignee/inventor and subject matter) shown on Google Patents for that specific record. Patent numbers that look similar can sometimes refer to different inventions, and “WO2000062778A1” alone doesn’t tell us the drug or target pathway.

If you paste the Google Patents link (or the title/abstract text), I can tell you:
- whether it names dasatinib directly,
- what chemical structure/classes it covers,
- what therapeutic indication is claimed, and
- whether it appears to be a formulation, synthesis, method-of-use, or polymorph-related filing.

Where to find it on Google Patents

Search Google Patents directly using the exact identifier:
- “WO2000062778A1”

If you share the resulting page URL, I can interpret the key sections (claims, summary/abstract, assignee, priority dates) and map them to dasatinib-related concepts.

Is it likely to be a dasatinib patent?

Dasatinib is a cancer drug (a kinase inhibitor) and most dasatinib-related patent families are typically associated with its development by the original brand/patent holders (commonly through early 1990s–2000s priority filings). A WO publication number alone doesn’t establish that the content is dasatinib; it could be about a different compound or a different family member unless the abstract/claims mention dasatinib (or the same core scaffold).

If you’re researching for infringement or freedom-to-operate

To determine whether a specific WO publication is “relevant to dasatinib,” the usual practical step is to compare:
- claimed compounds (does it include dasatinib by name or by structure class?),
- claimed methods/indications,
- jurisdiction and filing family (which countries entered),
- priority and term/expiry status (and any adjustments),
- later patent links in the same family.

If you share the Google Patents page (or the claims/abstract), I can do that relevance check.

Can you link me the Google Patents page?

Send either:
1) the Google Patents URL for WO2000062778A1, or
2) the title + abstract (copy/paste)

…and I’ll confirm the connection to dasatinib and summarize what the patent actually claims.

Sources

No sources were cited because no Google Patents or other document details were provided for WO2000062778A1.



Other Questions About Dasatinib :

cn1348370a dasatinib google patents bms dasatinib synthesis patent 2000 ep1169038 dasatinib google patents sprycel dasatinib price dasatinib synthesis patent 2000 bristol myers squibb Dasatinib patent expiry? How does Dasatinib treat leukemia?